Chemokine Gene-modified Cells for Cancer Immunotherapy

Described herein are methods of cancer immunotherapy, particularly compositions comprising genetically-modified cells that express macrophage colony stimulating factor (GM-CSF), CD40 ligand (CD40L), and chemokine C-C motif ligand 21 (CCL21), wherein the population of cells comprises bystander cells and target cancer cells, and methods of making these compositions and treating cancer using these compositions.

Attached files:
US 20110059137.jpg

Patents:
US 20,110,059,137

Inventor(s): ANTONIA SCOTT JOSEPH [US]; MULE JAMES J [US]

Type of Offer: Licensing

Contact Patent Owner or Broker


Next Patent »
« More Genetics Patents

Share on      

CrowdSell Your Patent